e-learning
resources
Paris 2018
Sunday, 16.09.2018
Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis
A. Berti (Milan, Italy), G. Volcheck (Rochester, United States of America), D. Cornec (Brest, France), R. Smyth (Dublin, Ireland), U. Specks (Rochester, United States of America), K. Keogh (Rochester, United States of America)
Source:
International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session:
Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type:
Thematic Poster
Number:
1135
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Berti (Milan, Italy), G. Volcheck (Rochester, United States of America), D. Cornec (Brest, France), R. Smyth (Dublin, Ireland), U. Specks (Rochester, United States of America), K. Keogh (Rochester, United States of America). Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis. 1135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Chronic nasal inflammation in asthmatic patients with eosinophilic granulomatosis with polyangitis (EGPA)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Severe Asthma in Children
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
An animal model for granulomatosis with polyangiitis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): Service evaluation in a regional severe asthma centre in North-west England
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
“A Study of Infective Etiology in Patients With Acute Exacerbation of COPD”
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
DRESS to Impress: A Case of Eosinophilic Bronchiectasis with Systemic Sequelae
Source: Virtual Congress 2021 – CCC Paediatric respiratory diseases
Year: 2021
The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Characteristics of eosinophilic severe asthmatics in the Wessex Severe Asthma Cohort (WSAC)
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept